Lobby organisation
Affordable Medicines Europe
Business group · Health & pharma · HQ: Belgium · Transparency Register entry
As of 7 November 2026, Affordable Medicines Europe appears in 57 declared MEP meetings (36 different MEPs), most often with European People's Party.
In their own words
“Affordable Medicines Europe represents Europe’s licensed parallel distribution industry, an integral part of the European pharmaceutical market that adds value to society by introducing price competition – especially for patented medicines – and a supplementary layer of product safety. In this our members work every day to make medicines more affordable for European healthcare systems and patients.”
Read the rest of the statementShow less of the statement
“Our industry has an annual turnover of 7.7 billion Euro. Through the direct membership of 15 national associations and individual companies, Affordable Medicines Europe's has 105 member companies in 21 EU and EEA Member States and the UK. These members account for approximately 80% of the total parallel import market volume in the area. Membership of Affordable Medicines Europe is exclusive to companies holding a wholesale (GDP) license (export and import). All importing members furthermore are GMP licensed.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 57 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2020–2026. Bar length is relative to its busiest year (32 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 1 Jun 2026 | Tiemo Wölken | MDR/IVDR Revision |
| 11 May 2026 | Valentina Palmisano | Medical devices |
| 4 May 2026 | Maria Guzenina | Exchange of views on medical devices regulation |
| 28 Jan 2026 | Paolo Inselvini | company presentation |
| 26 Nov 2025 | Nicolás González Casares | Pharmaceutical Legislation |
| 5 Nov 2025 | Nicola Zingaretti | presentation of the association |
| 5 Nov 2025 | Mariateresa Vivaldini | Meeting conoscitivo |
| 5 Nov 2025 | Salvatore de Meo | Pharmaceuticals |
| 27 Oct 2025 | Michalis Hadjipantela | Meeting about CMA |
| 29 Sep 2025 | Adam Jarubas | Pharma Package |
| 26 Sep 2025 | Marion Walsmann | CMA |
| 25 Sep 2025 | Pablo Arias Echeverría | Position and priorities of Europe’s licensed independent medicine distribution sector |
| 15 Jul 2025 | Tiemo Wölken | Pharma Package |
| 9 Jul 2025 | Dan-Ştefan Motreanu | 'Single Market for Medicines' initiative |
| 8 Jul 2025 | Tilly Metz | Critical Medicines Act |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.